BioCentury
ARTICLE | Clinical News

Amiscan: Began Phase I testing

July 17, 2000 7:00 AM UTC

Draxis Health Inc. (DRAX; TSE:DAX), Mississauga, Ontario Product: Amiscan Business: Diagnostics/Imaging Therapeutic category: Imaging agent Target: NA Description: Technetium-labeled D-glucaric acid ...